The Office of the Chief Scientist approved NIS 8.2 million in funding for four new incubator projects, the Ministry of Industry, Trade and Labor said Sunday.
Two of the companies are active in research in the medical device market - Audiodent Israel, which has developed a hearing aid fitted to the patient's mouth, and Stimplant, from the Meytav Technology Incubator, which has developed a device for treating obesity. The other two investments were made in the biotechnology field - the Bioline Jerusalem Incubator, which is developing a small molecule for the treatment of pain, and Nazereth-based New Generation Technology, which is working on the ablation of cancerous tissue.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>